JWD
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Wildlife Diseases, 46(1), 2010, pp. 246-250
© Wildlife Disease Association  2010
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Cattet, M. R. L.
Right arrow Articles by Obbard, M. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cattet, M. R. L.
Right arrow Articles by Obbard, M. E.

SHORT COMMUNICATION

Use of Hyaluronidase to Improve Chemical Immobilization of Free-ranging Polar Bears (Ursus maritimus)

Marc R. L. Cattet1,3 and Martyn E. Obbard2

1 Canadian Cooperative Wildlife Health Centre, Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Dr., Saskatoon, Saskatchewan S7N 5B4 Canada
2 Wildlife Research and Development Section, Ontario Ministry of Natural Resources, DNA Building, Trent University, 2140 East Bank Dr., Peterborough, Ontario K9J 7B8 Canada

3 Corresponding author (email: marc.cattet{at}usask.ca)

ABSTRACT:   We assessed the efficacy and safety of hyaluronidase to improve chemical immobilization of free-ranging polar bears (Ursus maritimus) captured from helicopter by remote drug delivery along the Ontario coast line of northwestern James Bay and southern Hudson Bay during September 2005 and October 2007. We used a single blind study design in which one person prepared and loaded all darts without the shooter knowing whether hyaluronidase (150 IU per dart) or sterile water was added to the immobilizing drug mixture of xylazine and zolazepam-tiletamine (XZT). We found that we often required more than one dart to immobilize bears in the control group (XZT+sterile water; >1 dart for 15 of 28 captures) versus the treatment group (XZT+hyaluronidase; >1 dart for seven of 26 captures). As a consequence, treatment bears were generally immobilized with smaller XZT dosages (7.9 vs. 9.4 mg/kg; P = 0.08) and shorter induction (10 vs. 15 min; P = 0.004) than control bears. We found no differences in vital rates and serum biochemistry results between control and treatment bears. We did find, however, that induction times correlated directly with rectal temperature at ≤15 min after immobilization (r = 0.39, P = 0.004), which suggests that use of hyaluronidase also helped prevent development of high body temperature (hyperthermia) in polar bears. Overall we found hyaluronidase to be effective and safe for capture of polar bears. We recommend further study to determine whether effects of hyaluronidase are dose dependent and recommend that others involved with capture of seasonally fat species such as polar bears consider use of hyaluronidase to improve chemical immobilization.
  Key words:  Chemical immobilization, hyaluronidase, polar bear, Ursus maritimus, xylazine, XZT, zolazepamtiletamine.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2010 by the Wildlife Disease Association.